omniture
LUNIT INC

Latest News

Lunit to Highlight New AI Evidence in Cancer Screening and Breast Density-Driven Risk Modeling at RSNA 2025

Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and ...

2025-12-02 22:10 843

Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research

DURHAM, N.C. and SEOUL, South Korea, Nov. 20, 2025 /PRNewswire/ -- Lunit, a leading provider of AI ...

2025-11-20 13:01 1376

Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025

Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardize...

2025-11-07 22:05 1656

Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence

The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, ...

2025-11-07 08:14 1010

Volpara Earns ACR® Learning Network Vendor Partner Designation

LYNNWOOD, Wash., Oct. 16, 2025 /PRNewswire/ -- Volpara Health has qualified for the American Colleg...

2025-10-16 21:00 1185

Lunit AI Predicts Immunotherapy Outcome in Colorectal, Kidney, and Lung Cancer at ESMO 2025

AI-powered histopathology demonstrates predictive value for immunotherapy outcomes in pMMR mCRC, ad...

2025-10-14 21:00 946

Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials

SEOUL, South Korea and MONTREAL, Sept. 24, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading pr...

2025-09-24 21:00 1995

Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine

Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize b...

2025-09-22 21:00 1822

Lunit Showcases AI-Powered Cancer Ecosystem at APEC High-Level Meeting on Health and the Economy and World Bio Summit 2025

Lunit highlights global leadership in cancer AI alongside world health experts with dedicated APEC ...

2025-09-16 21:00 5015

Lunit Awarded Major National Tender in France, Expanding Access to Breast AI in Public Hospitals

Framework agreement with UniHA enables access to Lunit's breast AI solutions across 1,500+ French p...

2025-09-11 21:00 1871

Lunit Selected as Exclusive AI Partner for Spain's Valencian Community Breast Screening Program

Milestone European deployment underscores growing global trust in Lunit's AI for population-wide br...

2025-09-02 21:00 1910

Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis

SEOUL, South Korea, July 2, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI fo...

2025-07-02 21:00 2176

Lunit Launches Enhanced Lunit INSIGHT CXR4, Secures CE MDR Certification for Expanded AI Capabilities

Next-generation AI solution introduces new clinical features and broader disease detection for ches...

2025-05-28 21:00 2390

Lunit Highlights AI's Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies

SEOUL, South Korea, May 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI fo...

2025-05-26 21:00 2069

Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition

Building on Volpara's breast health expertise, Lunit strengthens its U.S. presence—now delivering A...

2025-05-19 21:00 2326

Lunit to Power Germany's Largest Private Radiology Network with AI Imaging

The five-year framework agreement covers phased rollout of Lunit's AI suite—including chest X-ray, ...

2025-05-07 21:00 2385

SimonMed Imaging Partners with Lunit to Deliver Best-in-Class AI for Breast Cancer Detection

A Major Leap Forward in Patient Health and the Future of Mammography PHOENIX, April 23, 2025 /PRNew...

2025-04-24 00:00 2401

Lunit Study in Radiology Highlights Trust Gap Between Radiologists and AI in Breast Cancer Screening

Despite strong performance from AI, fewer recalls from AI-flagged cases point to challenges in huma...

2025-04-09 21:00 2763

Lunit Announces Partnership with the National Cancer Institute to Advance AI-Powered Biomarker Research

Collaboration to apply Lunit's AI technologies across NCI's broad spectrum of cancer studies, aimin...

2025-03-31 21:00 2257

Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca

AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance ...

2025-03-26 21:00 2037
12345 ... 7